Metherbin 0.2mg Injection
Marketer
May and Baker Pharmaceuticals Ltd
Salt Composition
Methylergometrine (0.2mg)
Overview Metherbin 0.2mg Injection
Uterine hemorrhage following childbirth or termination of pregnancy may be managed with Metherbin 0.2mg Injection. This medication acts on uterine smooth muscle, enhancing contractility (tone, rate, and amplitude) to minimize blood loss. Administered intravenously or intramuscularly by a physician in a hospital setting, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on your individual needs and response to treatment. The prescribed amount aims to alleviate symptoms effectively. Headache, elevated blood pressure, and convulsions are potential side effects; report any concerning symptoms to your doctor immediately, as mitigating strategies may be available. Alcohol consumption should be avoided during treatment. Prior to commencing therapy, inform your physician of any pre-existing heart conditions or hypertension, and provide a complete list of all other medications you are currently using, as potential interactions may affect Metherbin's efficacy or mechanism of action.
Primary Ingredients of Metherbin 0.2mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Metherbin 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Metherbin 0.2mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Metherbin 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Metherbin 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Metherbin 0.2mg Injection works:
Ergot alkaloid Metherbin Injection (0.2mg) induces prolonged uterine smooth muscle contractions. This vascular compression effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Metherbin 0.2mg Injection is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Metherbin 0.2mg Injection during pregnancy carries a substantial risk. Pregnant individuals should consult their physician; research in animal and human studies reveals considerable adverse effects on fetal development.
Breast feedingCAUTION
Administering Metherbin 0.2mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
The effect of Metherbin 0.2mg Injection on driving ability is undetermined. Refrain from driving if you develop any symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Metherbin 0.2mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Metherbin 0.2mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Metherbin 0.2mg Injection :
NA
Facts to Know About Metherbin 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Type | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | Drugs inducing uterine contraction and abortion |
3,018 People bought this recently